Skip to main content
. 2020 Mar 15;10(10):4544–4556. doi: 10.7150/thno.40532

Figure 1.

Figure 1

The liquid biopsy markers (LBMs) commonly used in clinical or laboratory screening include circulating tumor proteins, circulating tumor ctDNA, circulating tumor cells (CTCs), tumor-derived extracellular vesicles (EV) and their components, circulating tumor ctRNA and tumor-cultured platelets (TEPs). All of them can be used directly or indirectly for cancer screening and diagnosis.